Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
D - INNOVATE Corp. (0001006837) (Filer)
10-Q - INNOVATE Corp. (0001006837) (Filer)
8-K - INNOVATE Corp. (0001006837) (Filer)
- Infrastructure: Improved financial flexibility with recent refinancing transactions -- Life Sciences: R2 continuing to see significant year over year growth in system unit sales -- Spectrum: Launched fourth ATSC 3.0 station in collaboration with large mobile carrier - NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE) announced today its consolidated results for the second quarter. Financial Summary (in millions, except per share amounts)Three Months Ended June 30, Six Months Ended June 30, 2025 2024 Increase / (Decrease) 2025 2024 Increase / (Decrease) Revenue$242.0 $313.1 (22.7)% $516.2 $628.
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") today announced that it has closed a series of previously announced indebtedness refinancing transactions that will, among other things, exchange or amend existing instruments representing 81.7% of the total outstanding principal amount of the Company's debt as of June 30, 2025 for instruments with longer maturities. The refinancing transactions include (i) the initial closing of an exchange offer and consent solicitation with respect to the Company's senior secured notes, (ii) privately negotiated exchanges of certain of the Company's convertible senior notes, (iii) amendment and extensio
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today that DBM Global Inc. ("DBMG"), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE, will pay a cash dividend of approximately $4.4 million, or $1.14 per share, on August 21, 2025 to DBMG's stockholders of record at the close of business on August 7, 2025. As the largest stockholder of DBMG, INNOVATE expects to receive approximately $4 million of the total $4.4 million dividend payout. INNOVATE's individual stockholders are not eligible to receive the cash dividend. About INNOVATEINNOVATE Corp. is a portfolio
4 - INNOVATE Corp. (0001006837) (Issuer)
4 - INNOVATE Corp. (0001006837) (Issuer)
4 - INNOVATE Corp. (0001006837) (Issuer)
- Infrastructure: Improved financial flexibility with recent refinancing transactions -- Life Sciences: R2 continuing to see significant year over year growth in system unit sales -- Spectrum: Launched fourth ATSC 3.0 station in collaboration with large mobile carrier - NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE) announced today its consolidated results for the second quarter. Financial Summary (in millions, except per share amounts)Three Months Ended June 30, Six Months Ended June 30, 2025 2024 Increase / (Decrease) 2025 2024 Increase / (Decrease) Revenue$242.0 $313.1 (22.7)% $516.2 $628.
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") today announced that it has closed a series of previously announced indebtedness refinancing transactions that will, among other things, exchange or amend existing instruments representing 81.7% of the total outstanding principal amount of the Company's debt as of June 30, 2025 for instruments with longer maturities. The refinancing transactions include (i) the initial closing of an exchange offer and consent solicitation with respect to the Company's senior secured notes, (ii) privately negotiated exchanges of certain of the Company's convertible senior notes, (iii) amendment and extensio
NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") today announced the early participation results as of 5:00 p.m., New York City time, on July 30, 2025 (the "Early Participation Deadline") of its previously announced exchange offer and consent solicitation (the "Exchange Offer") to eligible holders of its 8.5% Senior Secured Notes due 2026 (the "Existing Senior Secured Notes") to exchange such Existing Senior Secured Notes for newly issued 10.5% Senior Secured Notes due 2027 (the "New Senior Secured Notes"). Additionally, the Company today announced that it will extend eligibility to receive the Total Early Exchange Consideration (as defin
4 - INNOVATE Corp. (0001006837) (Issuer)
4 - INNOVATE Corp. (0001006837) (Issuer)
4 - INNOVATE Corp. (0001006837) (Issuer)
MediBeacon expands management team as enrollment in Phase 3 study focused on kidney disease is completed ST. LOUIS, May 16, 2023 /PRNewswire/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE:VATE), today announced the appointment of Dr. Steve Miller as chief medical officer. In this role, Dr. Miller will be focused on driving a range of clinical and strategic initiatives. Dr. Miller formerly served as executive vice president and chief clinical officer at Cigna, where he led the company's clinical policy, quality, and per
Catalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced the appointment of Joseph A. Ferraro as Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary. Mr. Ferraro will be responsible for managing Catalent's global legal and compliance operations. He will be based at the company's headquarters in Somerset, New Jersey, head up the company's Legal Leadership Team, and serve on its Executive Leadership Team, reporting directly to Catalent's Executive Vice President and Chief Administrative Officer, Steven Fasman. This press release features multimedia. View the full release here: https:/
NEW YORK, Aug. 02, 2022 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE), today announced the appointment of Amy Wilkinson to fill the remaining vacancy on the INNOVATE Board of Directors. "Amy brings a unique blend of management expertise and global business and policy experience, and we are confident she will help guide us in our mission to drive shareholder value across our Infrastructure, Life Sciences and Spectrum operating segments," said Avie Glazer, Chairman of INNOVATE. "Amy's leadership and strategy consulting experience advising Fortune 500 companies will be a valuable addition to our Board," said Wayne Barr, Jr., Chief Executive Officer of INNOVATE
SC 13G/A - INNOVATE Corp. (0001006837) (Subject)
SC 13D/A - INNOVATE Corp. (0001006837) (Subject)
SC 13D/A - INNOVATE Corp. (0001006837) (Subject)